(Q49089802)

18 February 2018

title

Short regimen of praziquantel in the treatment of single brain enhancing lesions. (English)

1 reference

18 February 2018

1 reference

Pretell EJ

1

1 reference

18 February 2018

Garcia HH

2

1 reference

18 February 2018

Custodio N

3

1 reference

18 February 2018

Padilla C

4

1 reference

18 February 2018

Alvarado M

5

1 reference

18 February 2018

Gilman RH

6

1 reference

18 February 2018

Martinez M

7

1 reference

18 February 2018

publication date

1 December 2000

1 reference

18 February 2018

Clinical Neurology and Neurosurgery

published in

1 reference

18 February 2018

volume

102

1 reference

18 February 2018

issue

4

1 reference

18 February 2018

page(s)

215-218

1 reference

18 February 2018

Etiology and management of single small CT lesions in patients with seizures: understanding a controversy

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Cysticercosis mimicking brain tumor: the role of albendazole as a diagnostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Albendazole in single CT ring lesions in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

The use of albendazole in patients with single lesions enhanced on contrast CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Albendazole therapy in children with focal seizures and single small enhancing computerized tomographic lesions: a randomized, placebo-controlled, double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Single-day praziquantel therapy for neurocysticercosis

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Single-day praziquantel versus 1-week albendazole for neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Magnetisation transfer magnetic resonance imaging demonstration of perilesional gliosis--relation with epilepsy in treated or healed neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Edema associated with calcified lesions in neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Albendazole therapy for persistent, solitary cysticercus granulomas in patients with seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

Incidence and significance of adverse effects of albendazole therapy in patients with a persistent solitary cysticercus granuloma.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-8467%2800%2900110-4

7 January 2021

10.1016/S0303-8467(00)00110-4

Identifiers

DOI

1 reference

18 February 2018

PubMed ID

11154807

1 reference

18 February 2018